Victor Edward Tong Jr.
CIK: 0002007923
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 14, 2026AARD
Aardvark Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
45K shares- - Jun 4, 2026CGON
CG Oncology, Inc.
Award(A)DirectDirector Stock Option (right to buy)
9.4K shares- - Jun 11, 2025AARD
Aardvark Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
61K shares- - Jun 5, 2025CGON
CG Oncology, Inc.
Award(A)DirectDirector Stock Option (right to buy)
24.2K shares- - Oct 4, 2024CGON
CG Oncology, Inc.
Award(A)DirectStock Option (Right to Buy)
15.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 | AARD Aardvark Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 44,964 | - | - | Direct |
| Jun 4, 2026 | CGON CG Oncology, Inc. | Award(A) Director Stock Option (right to buy) | 9,354 | - | - | Direct |
| Jun 11, 2025 | AARD Aardvark Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 61,017 | - | - | Direct |
| Jun 5, 2025 | CGON CG Oncology, Inc. | Award(A) Director Stock Option (right to buy) | 24,165 | - | - | Direct |
| Oct 4, 2024 | CGON CG Oncology, Inc. | Award(A) Stock Option (Right to Buy) | 15,600 | - | - | Direct |
1-5 of 5 transactions
About Tong Victor Edward Jr
Tong Victor Edward Jr (SEC CIK 0002007923) files insider reports with the SEC as Director of Aardvark Therapeutics, Inc. (AARD) and Director of CG Oncology, Inc. (CGON).
Signal8 holds 6 ownership filings by Tong Victor Edward Jr (1 Form 3, 5 Form 4), filed between Oct 7, 2024 and Aug 21, 2026. Those filings report 5 transactions, from Oct 4, 2024 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Tong Victor Edward Jr's filings is in SAN DIEGO, CA.
Recent filings by Tong Victor Edward Jr
- Aug 14, 2026: Grant or award of AARD derivative securities (Form 4, code A).
- Jun 4, 2026: Grant or award of CGON derivative securities (Form 4, code A).
- Jun 11, 2025: Grant or award of AARD derivative securities (Form 4, code A).
- Jun 5, 2025: Grant or award of CGON derivative securities (Form 4, code A).
- Oct 4, 2024: Grant or award of CGON derivative securities (Form 4, code A).
Other insiders filing for Aardvark Therapeutics, Inc. (AARD)
- Zhang Zhongwei, Director
- Sun Nelson
- Chi Jeffrey, Director
- Graf Susan E, Director
- Baynes Roy D., Director
- Jaiman Manasi, Chief Medical Officer